收藏切换
Hua Chan Su activates PERK-eIF2α-ATF4 signaling to induce apoptosis and inhibit epithelial mesenchymal transition in non-small cell lung cancer
收藏切换
Yi-chen LIU1, Qiu-ying YAN1, Dan DONG1, Hua-ying ZHU2, Li-hui-ping TAO1, Min-min FAN1, Wei-xing SHEN1, Hai-bo CHENG1, 3, Dong-dong SUN1, *
Acta Pharmaceutica Sinica | 2025, 60(10) : 3060 - 3073
Less
收藏切换
Acta Pharmaceutica Sinica | 2025, 60(10): 3060-3073
• Original Articles •
Hua Chan Su activates PERK-eIF2α-ATF4 signaling to induce apoptosis and inhibit epithelial mesenchymal transition in non-small cell lung cancer
Full
Yi-chen LIU1, Qiu-ying YAN1, Dan DONG1, Hua-ying ZHU2, Li-hui-ping TAO1, Min-min FAN1, Wei-xing SHEN1, Hai-bo CHENG1, 3, Dong-dong SUN1, *
Affiliations
  • 1Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China
  • 2China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Shenzhen 518000, China
  • 3The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China
Published: 2025-10-12 doi: 10.16438/j.0513-4870.2025-0081
Outline
收藏切换

This study aimed to investigate the inhibitory effects of Hua Chan Su (HCS) on non-small cell lung cancer (NSCLC) both in vitro and in vivo, and to elucidate the molecular mechanism by which it induces endoplasmic reticulum (ER) stress. Firstly, using the CCK-8 assay to assess the proliferation of human lung adenocarcinoma A549 cells, it was found that HCS significantly inhibited cell proliferation and reduced migratory capacity. Transcriptome sequencing revealed that HCS down-regulated anti-apoptotic genes such as B-cell lymphoma-2 (Bcl2) and was enriched in signaling pathways related to the cell cycle, apoptosis, and ER stress. Further studies demonstrated that HCS enhanced mitochondrial oxidative stress, increased the expression of Bcl2 associated X, decreased the expression of Bcl2, and induced apoptosis. Western blot analysis showed that HCS significantly activated the protein kinase RNA-like endoplasmic reticulum kinase (PERK)-eukaryotic initiation factor 2α (eIF2α)- activating transcription factor 4 (ATF4) signaling pathway in vitro. Combined with a PERK inhibitor, it was confirmed that HCS could trigger apoptosis through the ER stress pathway. In animal experiments, oral administration of HCS (2 and 4 g·kg-1) for 14 consecutive days significantly inhibited the growth of NSCLC xenografts, with no observed toxicity in major organs. TUNEL staining and Western blot analysis further confirmed that HCS induced tumor cell apoptosis in vivo (all animal experiments were approved by the Institutional Animal Ethics Committee of Nanjing University of Chinese Medicine, approval number: ACU240307). Serum biochemical results suggested that HCS improved liver function and oxidative stress status. In addition, immunohistochemical analysis showed that HCS down-regulated mesenchymal markers such as vimentin, α-smooth muscle actin (α-SMA), and fibroblast activation protein 1 (FAP1), while up-regulating E-cadherin levels, significantly inhibiting the epithelial mesenchymal transition (EMT) process in NSCLC cells. In conclusion, HCS can activate the PERK-eIF2α-ATF4 signaling pathway to induce tumor cell apoptosis and inhibit EMT, indicating its potential application value in the treatment of non-small cell lung cancer.

Hua Chan Su  /  non-small cell lung cancer  /  transcriptomics  /  apoptosis  /  endoplasmic reticulum stress  /  epithelial mesenchymal transition
刘熠晨, 闫秋莹, 董丹, 祝华英, 陶李蕙苹, 范旻旻, 沈卫星, 程海波, 孙东东. 华蟾素激活PERK-eIF2α-ATF4信号诱导非小细胞肺癌凋亡并抑制上皮间质转化. 药学学报, 2025 , 60 (10) : 3060 -3073 . DOI: 10.16438/j.0513-4870.2025-0081
Yi-chen LIU, Qiu-ying YAN, Dan DONG, Hua-ying ZHU, Li-hui-ping TAO, Min-min FAN, Wei-xing SHEN, Hai-bo CHENG, Dong-dong SUN. Hua Chan Su activates PERK-eIF2α-ATF4 signaling to induce apoptosis and inhibit epithelial mesenchymal transition in non-small cell lung cancer[J]. Acta Pharmaceutica Sinica, 2025 , 60 (10) : 3060 -3073 . DOI: 10.16438/j.0513-4870.2025-0081
Year 2025 volume 60 Issue 10
253
119
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2025-0081
  • Receive Date:2025-01-21
  • Online Date:2026-09-20
  • Published:2025-10-12
Article Data
Affiliations
History
  • Received:2025-01-21
  • Revised:2025-07-05
Affiliations
    1Jiangsu Collaborative Innovation Center of Traditional Chinese Medicine in Prevention and Treatment of Tumor, Nanjing University of Chinese Medicine, Nanjing 210023, China
    2China Resources Sanjiu Medical & Pharmaceutical Co., Ltd., Shenzhen 518000, China
    3The First Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing 210023, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2025-0081
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT